Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Palisade Bio, Inc. (PALI) had Tangible Shareholders Equity of $3.21M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-2.87M |
|
-- |
|
-- |
|
$2.92M |
|
$-2.92M |
|
$0.05M |
|
$-2.87M |
|
$-2.87M |
|
$-2.87M |
|
$-2.87M |
|
$-2.87M |
|
$-2.87M |
|
$-2.92M |
|
$-2.92M |
|
7.47M |
|
7.47M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$6.83M |
|
-- |
|
$0.14M |
|
$6.97M |
|
$3.48M |
|
-- |
|
$0.28M |
|
$3.76M |
|
$3.21M |
|
|
Tangible Shareholders Equity |
$3.21M |
$3.21M |
|
9.12M |
|
| Cash Flow Statement Financials | |
$-7.70M |
|
-- |
|
$3.11M |
|
$9.85M |
|
$5.25M |
|
$-4.59M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.96 |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-89.35% |
|
-89.29% |
|
-41.13% |
|
-89.29% |
|
$0.35 |
|
$-1.03 |
|
$-1.03 |
|